Clinical · Molecular biology · Bioinfo & AI
Deep molecular profiling of lung neuroendocrine tumours and supra-carcinoids
Summary
This study conducted deep multi-omic analyses on over 300 lung neuroendocrine tumours (NETs) and supra-carcinoids, integrating whole-genome sequencing, transcriptome profiling, and DNA methylation arrays. Researchers identified four strikingly different molecular groups, varying in patient characteristics, genomic and transcriptomic profiles, microenvironment, and morphology. A new molecular group, enriched for highly aggressive supra-carcinoids with an immune-rich microenvironment linked to tumor-macrophage crosstalk, was discovered. This morpho-molecular classification unifies previous proposals and offers potential implications for prognosis and therapeutic management, particularly through the identification of group-specific therapeutic targets such as DLL3, EGFR, FGFR, and TERT.
Critical appraisal
Clinical. This study has significant clinical impact by proposing a new morpho-molecular classification for lung NETs that outperforms current histological criteria. The identification of four distinct groups, including a new aggressive supra-carcinoid group, would allow for more precise patient stratification. The validation of an IHC marker panel and the use of deep learning models for group identification facilitate their future clinical implementation, potentially within 3 to 5 years. This classification paves the way for group-specific therapeutic opportunities, potentially targeting DLL3, EGFR, FGFR, and TERT, justifying clinical trials to evaluate these targeted approaches.
Molecular biology. The study made a major molecular discovery by identifying four distinct molecular groups of lung NETs through an exhaustive multi-omic approach (whole-genome sequencing, transcriptome profiling, DNA methylation arrays, spatial RNA-seq, proteomics). The discovery of a new aggressive supra-carcinoid group, characterized by an immune-rich microenvironment and tumor-macrophage crosstalk, is crucial. The identification of an undifferentiated cell population and transcriptomic similarities with atypical high-grade small cell lung carcinomas enhances the understanding of these tumors' biology and provides potential biomarkers and therapeutic targets for future clinical testing.
Bioinfo & AI. The bioinformatics aspect is central with the integration of multi-omic data and archetype analysis to characterize the molecular groups. Furthermore, the study developed deep learning models capable of accurately identifying these groups from whole slide images, outperforming current histological criteria. This approach represents a significant advance for diagnosis, offering a reproducible and potentially clinically deployable tool to improve lung NET classification and guide therapeutic decisions, by replacing or complementing manual evaluation.
The summary and the appraisal were written by a language model from the title and abstract of the original article. A curator decided to publish it. Methodology